neurosteroid – CFN Media

PureTech’s LYT-300 (Oral Allopregnanolone) Demonstrates Oral Bioavailability, Tolerability and GABAA Receptor Target Engagement in Healthy Volunteers

Orally administered LYT-300 achieved blood levels of allopregnanolone at or above those…

Ryan Allway
December 19, 2022

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

How to Invest in the LFP Electric Battery Boom

All electric cars, whether fully electric or hybrid, need some form of…

Robin Lefferts
November 6, 2024

Top News

Introducing LEEF Brands, Vertically Integrated California Powerhouse

The cannabis industry has fallen out of favor with many investors, in…

Ryan Allway
November 1, 2024

Aduro Clean Technologies Reports Fiscal 2025 First Quarter Results

LONDON, Ontario, Oct. 31, 2024 (GLOBE NEWSWIRE) — Aduro Clean Technologies…

Ryan Allway
October 31, 2024

CEO.CA Interviews Stallion Uranium CEO

Stallion Uranium Corp. (TSX.V: STUD) (OTCQB: STLNF) (FSE: FE0) CEO Drew Zimmerman…

Ryan Allway
October 29, 2024